Open-label, Randomized, Active-controlled Study of LEV Used as Monotherapy in Patients With Partial-Onset Seizures
Clinical trial NCT01954121 · COMPLETED
Trial details
- NCT number
- NCT01954121
- Sponsor
- UCB Pharma SA
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-09-01
- Primary completion
- 2015-09-01
- Enrollment
- 436
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.